Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines
- 1 October 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 107 (1) , 29-35
- https://doi.org/10.1016/0304-3835(96)04339-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of cellular adhesion molecules on human prostate tumor cell linesThe Prostate, 1995
- Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitusThe Lancet, 1994
- Cell adhesion in the immune systemImmunology Today, 1993
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growthThe Prostate, 1993
- Circulating Intercellular Adhesion Molecule-1 in Melanoma Patients: Induction by Interleukin-2 TherapyJournal of Immunotherapy, 1992
- Measurement of an adhesion molecule as an indicator of inflammatory disease activity: Up‐regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritisArthritis & Rheumatism, 1991
- Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseasesClinical and Experimental Immunology, 1991
- Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamilyCell, 1990
- Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicityEuropean Journal of Immunology, 1988